Ixabepilone [clinicaltrials_resource:36df6eba8c378a34fa9407c4fff03457]
intervention [clinicaltrials_vocabulary:intervention]
Ixabepilone [clinicaltrials_resource:36df6eba8c378a34fa9407c4fff03457]
Bio2RDF identifier
36df6eba8c378a34fa9407c4fff03457
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:36df6eba8c378a34fa9407c4fff03457
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Escalating doses 25-32 mg/m2 by intravenous infusion on day 1 of each 21 day cycle
intervention name [clinicaltrials_vocabulary:intervention-name]
Ixabepilone
other name [clinicaltrials_vocabulary:other-name]
IXEMPRA(TM)
identifier
clinicaltrials_resource:36df6eba8c378a34fa9407c4fff03457
title
Ixabepilone
@en
type
label
Ixabepilone [clinicaltrials_resource:36df6eba8c378a34fa9407c4fff03457]
@en